About Reviva

Reviva Pharmaceuticals is a privately held, late-stage clinical development pharmaceutical company that is developing a portfolio of internally discovered therapies that address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic and inflammatory diseases. Reviva has a strong patent portfolio and multiple products in the pipeline at various stages of development.       + Read More

March 10, 2015

SANTA CLARA, Calif.--(BUSINESS WIRE)--Reviva Pharmaceuticals, Inc., (Reviva), a privately held drug discovery and development company, announced today that it has appointed life sciences industry experts, Brian G. Atwood, Sarvajna Dwivedi and Peder K. Jensen to its Board of Directors. + Readmore